INTRODUCTION
============

AMPA-type glutamate receptors (AMPARs) consist of heterotetrameric complexes composed of subunits GluA1--4 ([@B19]). Each subunit confers specific properties on the active receptor, including trafficking motifs, phosphorylation sites, and many other protein--protein interactions ([@B44]). The GluA2 subunit is uniquely edited at the mRNA level, where a glutamine codon is switched to arginine ([@B29]), which confers channel resistance to calcium. Therefore, AMPAR complexes that lack GluA2 pass sodium and calcium ions resulting in higher conductance. In addition, calcium permeable AMPARs (CP-AMPARs) exhibit inward rectification in current--voltage plots that differs from the linear rectification of predominateAMPARs due to voltage-dependent block by intracellular polyamines ([@B7]; [@B12]). GluA2 lacking AMPARs can be formed through GluA1 homomers or combinations of GluA1, 3, and 4. However, detection of these complexes *in vivo* in excitatory principle neurons has been somewhat controversial. Using single-cell analysis and conditional knock-out (KO) mice Nicoll and colleagues found that hippocampal excitatory neurons consist mostly of GluA1/2 or GluA2/3 receptors, with very few homomers detected ([@B30]). It is unclear if this is similar in other brain regions. In contrast, other studies have detected GluA2-lacking receptors, primarily through pharmacological use of external polyamine toxins such as Joro toxin and philanthotoxin (PhTx) or electrophysiological (by measuring rectification) methods in hippocampal neurons. In most of these studies, however, CP-AMPARs were only detected in young animals or after an epoch of plasticity-inducing neuronal activity ([@B21]; [@B27]). In contrast, aspiny, inhibitory interneurons throughout the CNS express GluA2-lacking, CP-AMPARs ([@B22]; [@B17]). These receptors play an important role in interneuron synaptic plasticity including both Hebbian and anti-Hebbian forms ([@B2]; [@B25]).

Trafficking of AMPARs in and out of synapses is a major mechanism underlying synaptic plasticity ([@B44]). Recent studies have shown that subunit switching of AMPAR complexes plays an important role in long-term forms of synaptic plasticity such long-term potentiation (LTP), long-term depression (LTD), and homeostatic plasticity ([@B35]). This review concentrates on new findings that implicate CP-AMPARs in experience-dependent and synaptic plasticity (**Figure [1](#F1){ref-type="fig"}**). For brevity purposes, I focus only on the role of CP-AMPARs in excitatory neurons.

![**The role of CP-AMPARs in neuronal plasticity.** GluA2-lacking receptors are relatively rare at baseline conditions in most excitatory neurons. However, GluA1/2 heteromers are replaced with GluA1 homomers after the induction of numerous plasticity paradigms. Since GluA1 homomers conduct Na^+^ and Ca^2+^ ions, synaptic transmission is usually potentiated even if the absolute numbers of receptors are the same. Precisely how this AMPAR subunit switch or replacement takes place is unclear. In some cases homomers may be directly inserted without replacing heteromers, which would also cause net potentiation of synaptic transmission. Although the time-course of induction may differ, cocaine injection; fear conditioning; homeostatic scaling; and long periods of wakefulness all result in an increase in synaptic/surface CP-AMPARs, which usually results in potentiation of synaptic transmission. In many cases CP-AMPAR surface/synaptic expression is transient but removal of CP-AMPARs can be facilitated by the activation of group 1 mGluR activation, perhaps by synthesizing GluA2 subunits locally at synapses, which also results in mGluR-dependent synaptic depression.](fnmol-05-00049-g001){#F1}

SENSORY-DEPENDENT PLASTICITY
============================

Sensory information from the environment can have long-lasting changes on the brain. Many, now classic, experiments have used the sensory system to probe mechanisms of experience-dependent plasticity. These studies have been especially useful in defining the basic properties of cortical networks *in vivo* ([@B13]).

Rodents use their whiskers to explore their surroundings and the barrel cortex exhibits very stereotypic anatomy and plasticity, making it an excellent model to probe mechanisms of experience-dependent plasticity ([@B14]). Single whisker stimulation in the absence of adjacent whiskers results in potentiation of spared whisker responses in the cortex. This potentiation occurs through specific strengthening of excitatory transmission at layer 4-2/3 pyramidal neurons in the somatosensory cortex, only in neurons that respond to the intact whisker. This potentiation was accompanied by a change in AMPAR rectification properties suggesting a role of CP-AMPARs ([@B8]). More recently, the same group surprisingly found that CP-AMPARs were only transiently involved in this form of potentiation as 4-2/3 synapses older than P13 underwent potentiation but there was no evidence of CP-AMPARs. Moreover, CP-AMPARs do not underlie potentiation of layer 2/3-2/3 synapses, even when these synapses display robust single whisker-induced potentiation ([@B53]). This data suggests that the trafficking of CP-AMPARs is synapse specific, perhaps requiring distinct pools of AMPARs within the same post-synaptic cell ([@B24]) and tightly regulated during development. Precisely why these synapse-specific differences in AMPAR subunit trafficking occur remains a major question to be addressed.

ADDICTION
=========

Drugs of addiction have long-lasting effects on brain circuitry and often can induce changes rapidly with a single exposure. The expression mechanisms of drug-evoked plasticity have been explored, implicating AMPAR trafficking and plasticity as important molecular substrates ([@B31]). In the ventral tegmental area (VTA) of the basal ganglia, dopamine neurons are thought to be a prime mediator of drug-induced reward responses. One of the first studies implicating a role for CP-AMPARs in addiction found that a single injection of cocaine significantly increased the ratio of AMPAR/NMDAR responses (as measured by AMPA/NMDA EPSCs from midbrain slices) for approximately a week following the injection of cocaine ([@B51]). Prolonged self-administration of cocaine results in an increase in the AMPA/NMDA ratio that lasts several months. Electrophysiological measures suggested that the change in the ratio was caused partly by an increase in AMPAR-EPSCs. This increase was accompanied by a change in rectification properties ([@B6]), suggesting the presence of GluA2-lacking AMPARs. CP-AMPARs were confirmed by the sensitivity of the EPSCs to Joro toxin. However, thetotal numbers of AMPARs seemed to be the same, suggesting that a subunit switch had occurred rather than direct insertion of CP-AMPARs. What are the consequences of this subunit switch? Further studies revealed that induction protocols that would normally elicit LTP in DA neurons did not induce LTP in cocaine-treated animals and inverted the rules for the induction of synaptic plasticity ([@B51]; [@B33]) as described below. Normally depolarization induces potentiation of transmission because NMDARs become unblocked but cocaine administration reduced NMDAR currents, which would account for the lack LTP induction. Conversely, a slight hyperpolarization of DA neurons during afferent stimulation induced a strengthening of AMPAR transmission only in slices from mice that had received cocaine. This is probably due to the fact that CP-AMPARs are blocked under depolarizing conditions but pass more current when hyperpolarized. Thus, cocaine administration induces changes in the basal properties of excitatory synapses as well as in the rules that govern the induction of activity-dependent synaptic plasticity.

An intriguing idea that results from these findings is that reversing the AMPAR subunit switch may be a method to treat drug addiction. Activation of group 1 metabotropic glutamate receptors (mGluR1/5) in slices from cocaine-treated mice quickly removes CP-AMPARs and replaces them with GluA2-containing ones, leading to LTD ([@B5], [@B6]). This form of LTD requires rapid synthesis of GluA2 subunits via local translation from mRNA present in dendrites of DA neurons ([@B32]). Interfering with mGluR-LTD, via expression of a dominant-negative peptide that disrupts the mGluR1/5--Homer interaction selectively in the VTA, significantly prolongs the persistence of cocaine-evoked plasticity ([@B34]). Another recent study found AMPAR potentiation due to an increase in CP-AMPARs in the nucleus accumbens (NAc), another midbrain structure implicated in drug addiction ([@B10]). The CP-AMPAR antagonist 1-naphthylacetyl spermine (NASPM) was injected into the accumbens of cocaine-exposed rats before tests for cue-induced cocaine-seeking resulted in decreased cue-induced cocaine-seeking after cocaine withdrawal. The authors suggest that this potentiation mediates the incubation of cocaine craving due to increased reactivity of accumbens neurons to cocaine-related cues. As follow-up studies show, an mGluR1/5 agonist could reverse the abnormal accumulation of CP-AMPARs in the NAc ([@B37]) and depotentiation of cortical NAc inputs by optogenetic stimulation *in vivo* restored normal transmission and abolished cocaine-induced locomotor sensitization ([@B41]). Taken together, these results suggest that mGluR1/5 activation in VTA DA neurons may be a novel therapeutic target for addiction by decreasing the abnormal levels of CP-AMPARs.

CP-AMPAR INDUCED METAPLASTICITY IN MEMORY CONSOLIDATION
=======================================================

Fear memory has been extensively studied in rodents, with much of the circuitry now well defined ([@B42]). A standard protocol to induce fear memory involves pairing a tone \[a neutral cue/conditioned stimulus (CS)\] with a foot shock \[an unconditioned stimulus (US)\]. Cue-dependent fear conditioning is mediated by the potentiation of glutamatergic synaptic transmission in the lateral amygdala (LA) ([@B38]; [@B43]). In a recent study by [@B9] an enhancement of AMPAR-EPSCs at thalamic afferents to LA neurons occurs after auditory fear conditioning in mice. This enhancement was observed as both an increase in the AMPA/NMDA ratio as well as larger AMPAR miniature EPSC amplitudes and these changes lasted for days. Potentiation of AMPAR transmission was accompanied by a slowly developing enhancement of rectification that was sensitive to NASPM. These changes peaked at 24 h after conditioning but intriguingly were not evident 1 week later even though potentiation remained. This data suggests a transient role for CP-AMPARs in the expression of fear conditioning but not a role in the maintenance of potentiation or memory. This exquisite and specific stability of potentiation in the face of significant AMPAR subunit changes is remarkable considering the differences in channel properties of CP-AMPARs. Based on the cocaine studies discussed above, the authors sought out an LTD protocol that would remove CP-AMPARs and found that LTD (mediated through NMDA and mGluR1 receptors) was enhanced after fear conditioning in LA neurons. The authors then reasoned that removing CP-AMPARs could underlie protocols of fear memory extinction. Standard extinction protocols present the CS without a reinforcing US, resulting in diminished responses to the CS. However, the memory is not fully erased, as spontaneous recovery of the memory can occur by specific cues ([@B18]). In contrast, if the fear memory is retrieved or reactivated by a single presentation of the tone without the shock 1 hour before the extinction session, the fear responses are permanently removed ([@B39]). Previous studies have shown that recall of a memory renders that memory trace labile again, where it becomes sensitive to disruption in similar manner to when the original memory was being consolidated. Over a certain time period the memory is reconsolidated. [@B9] find that reconsolidation is blocked by mGluR1 antagonists and results in a decrease in AMPAR transmission that was previously potentiated by fear conditioning. This reversal in potentiation is due to the selective removal of CP-AMPARs, and the LTD induction was greatly reduced in mice receiving the retrieval--extinction protocol, compared with those receiving extinction alone. These findings suggest that the presence of CP-AMPARs renders the memory trace labile and allows full memory erasure or modification but only in a constrained time window. It will be of some interest to determine how CP-AMPARs mediate this phenomenon but the results are consistent with an emerging theme that CP-AMPARs allow metaplasticity (i.e., plasticity changes in response to the activity historyof the neuron) to occur ([@B1]).

HOMEOSTATIC AMPAR SCALING
=========================

Neuronal output is normally very stable and chronic changes in activity/input levels result in compensatory homeostatic changes that maintain a constant output ([@B49]). One particular mechanism of homeostatic plasticity involves the synaptic scaling of post-synaptic AMPARs ([@B50]). Levels of synaptic AMPARs scale up in conditions of low activity and down in conditions of high activity are typically evident in bidirectional changes in mini EPSC amplitude. The molecular mechanisms of AMPAR scaling are beginning to emerge and many studies have shown that CP-AMPARs play a role. AMPAR currents show inward rectification and become sensitive to CP-AMPAR antagonists after neuronal activity blockade ([@B48]; [@B47]) and scaling is blocked in neurons chronically incubated with PhTx ([@B20]). Moreover, molecules that can induce synaptic up-scaling of AMPARs such as retinoic acid and the cytokine tumor necrosis factor-alpha cause an increase in surface CP-AMPARs ([@B46]; [@B3]). Another molecular player involved in AMPAR scaling, Arc/arg3.1, may also preferentially regulate GluA1 during scaling as Arc KO neurons exhibit a significant increase in surface GluA1 but not GluA2 expression and synaptic scaling of AMPARs in the visual cortex is abolished both *in vitro* and *in vivo* ([@B45]; [@B16]; [@B36]). GluA2-lacking receptors are also inserted after prolonged inactivity at individual synapses, a form of very local homeostatic plasticity that is also Arc-dependent ([@B4]).

The role of GluA1 in scaling, however, does not seem to be universal. Tetrodotoxin (TTX) treatment, which blocks action potentials, induced synaptic scaling in cultured visual cortical neurons through the insertion of GluA2-containing AMPARs at synapses, which was blocked by a GluA2 C-tail peptide but not by a GluA1 C-tail peptide ([@B15]). Similarly, reducing GluA2 levels with a short hairpin RNA (shRNA) blocks synaptic scaling. These data are consistent with reports from cortical, hippocampal, and spinal cultures where scaling was induced by TTX-dependent activity blockade ([@B40]; [@B54]; [@B47]). In contrast, several other studies have shown that scaling induced by chronic action potential and NMDAR blockade (using the drug APV) together is mediated by CP-AMPARs ([@B23]; [@B48]; [@B47]). The discrepancy in these findings seems to result from the methods used to modulate neuronal activity, i.e., blockade using TTX, or APV or TTX + APV. The blocking of NMDARs seems to evoke local protein synthesis of GluA1 protein ([@B47]). It remains unclear why scaling would require CP-AMPARs or whether this type of scaling is qualitatively different from scaling mediated by GluA2.

CP-AMPARs ARE MODULATED BY SLEEP/WAKE CYCLES
============================================

Sleep remains one of the biggest enigmas in science. Why do we sleep and what why is it useful? Emerging evidence suggests that sleep is integral for normal brain functioning and memory consolidation ([@B11]). A leading theory suggests that sleep sub-serves a homeostatic role in maintaining optimal levels of synaptic transmission ([@B52]). At a simplistic level the theory proposes that during wakefulness net synaptic transmission slowly potentiates, perhaps due to LTP-like processes during learning. If synaptic transmission continues to potentiate learning may be obstructed due to saturation of net synaptic weights. The theory therefore contends that during sleep this potentiation is reversed due to LTD-like processes, which allows memory to consolidate. One study found increases in GluA1-containing AMPAR levels in synaptoneurosomes during wakefulness and decreases during sleep in both cortex and hippocampus. Other molecular changes in AMPAR, CaMKII, and GSK3β phosphorylation were also consistent with synaptic potentiation during wakefulness and with depression during sleep ([@B52]). Another study found that AMPAR mEPSCs, in slices of frontal cortex from mice and rats, were increased in frequency and amplitude after wakefulness and decreased after sleep ([@B28]). Consistent with these results, the slope and amplitude of field potentials increase during wakefulness and decrease during sleep in freely moving rats ([@B52]).

A recent study found that the trafficking of CP-AMPARs is modulated during sleep/wake cycles, perhaps via CP-AMPAR- dependent homeostatic AMPAR scaling ([@B26]). CP-AMPARs accounted for \~25% of total EPSP size in layer 5 cortical pyramidal neurons from somatosensory cortex at the end of the wakefulness/dark period as assessed using PhTx and rectification properties. In contrast EPSPs were PhTx insensitive with linear current--voltage characteristics at the end of the wake/light period. The CP-AMPAR removal during the wake period occurred gradually over time and was significant after 4 h. Similarly, CP-AMPARs were evident 4 h after light offset. The significance of these findings are unclear, but are very intriguing. Further investigation into the role of CP-AMPARs in sleep may shed light on the role of sleep in memory consolidation.

CONCLUSION
==========

Research on CP-AMPARs is in its infancy, but the role of CP-AMPARs in synaptic and experience-dependent plasticity is beginning to be elucidated. It seems clear that there are specific trafficking rules that govern when and where these particular AMPARs are expressed. A general theme that emerges from the studies above is that CP-AMPARs are transiently expressed after plasticity-inducing stimuli in many contexts. This transient expression is usually accompanied by potentiation of synaptic transmission. However, CP-AMPARs generally do not mediate maintenance of plasticity but instead seem to play a role in maintaining neural circuits in a "plasticity-ready" state (i.e., they act as a switch to turn on metaplasticity) that can then keep memory traces labile, but only in a time-delimited manner. Indeed, long-term expression of CP-AMPARs has been associated with neuronal pathology such as ischemia and therefore long-term expression of CP-AMPARs may have a detrimental effect on neuronal function ([@B27]).

Many questions remain and very little, at the mechanistic level, is known about how the expression of CP-AMPARs affects neuronal properties. Are there specific second messenger systems controlled through calcium flux via CP-AMPARs? What are the trafficking rules that govern activity-dependent CP-AMPAR expression? How are CP-AMPARs specifically removed and replaced by GluA2-containing AMPARs? Not only are these questions important for understanding basic brain function but, as seen in the studies mentioned in this article, CP-AMPARs may be an exciting new target for therapeutics in drug addiction and memory disorders.
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